Key result
Higher Framingham Risk Score is not associated with incident vasomotor menopausal symptoms.
Why the study?
The causal pathway between vasomotor menopausal symptoms and cardiovascular disease is unclear, motivating investigation of cardiovascular risk as a risk factor for VMS.
Does an unfavorable cardiovascular risk profile increase the risk of incident vasomotor menopausal symptoms in women aged 50-70?
Cohort (n=1,295)
Does an unfavorable cardiovascular risk profile increase the risk of incident vasomotor menopausal symptoms in women aged 50-70?
Odds Ratio: 0.98 (95% CI 0.95–1.01)
An unfavorable cardiovascular risk profile, as measured by the Framingham Risk Score, does not appear to be a risk factor for the development of vasomotor menopausal symptoms.
No association between unfavourable CV risk profile and incident VMS; leaves open vascular mechanisms in VMS etiology and requires confirmation in prospective cohorts.
OBJECTIVE: Evidence suggests an association between vasomotor menopausal symptoms (VMSs), i.e. hot flushes and night sweats, and cardiovascular disease. However, the causal pathway is unclear. We investigated whether an unfavourable cardiovascular risk profile is a risk factor for VMS later in life. DESIGN: Retrospective cohort study. SETTING: Women aged 50-70 from the general population. POPULATION: The Prospect-European Prospective Investigation into Cancer and Nutrition (Prospect-EPIC) cohort is a population-based cohort of women who enrolled between 1993 and 1997. Follow-up questionnaires were sent at 5-year intervals for 15 years. Women who returned the third questionnaire, answered questions regarding lifetime VMS and did not report VMS prior to baseline were included in this study (n = 1295). METHODS: At baseline, the Framingham Risk Score (FRS) was determined. We used logistic regression analysis to calculate odds ratios (ORs) for the association between baseline FRS and incident VMS. MAIN OUTCOME MEASURE: Incident VMS. RESULTS: At baseline (mean age ± standard deviation, 52.2 ± 3.6 years), 21.2% had a FRS > 10%. During follow-up, 40.2% of women reported the onset of VMS. Adjusted for body mass index, physical activity, education and alcohol consumption, each point increase in FRS was associated with a decreased incidence of VMS [OR, 0.94 (95% CI, 0.91-0.97)]. Additional adjustment for menopausal status attenuated the OR to null [OR, 0.98 (95% CI, 0.95-1.01)]. None of the separate FRS variables were associated with VMS after adjustment for age. CONCLUSIONS: In our cohort, an unfavourable cardiovascular risk profile was not associated with VMS, and therefore we found no evidence for the involvement of a vascular mechanism in the etiology of VMS.
No takes yet. Share an insight, caveat, or question.
Berg et al. (2014) conducted a cohort in Vasomotor menopausal symptoms (n=1,295). Framingham Risk Score was evaluated on Incident VMS (OR 0.98, 95% CI 0.95-1.01). A higher Framingham Risk Score was not associated with incident vasomotor menopausal symptoms after adjusting for menopausal status (OR 0.98; 95% CI 0.95-1.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: